PEGY
← Back to signals

IDXX

AVOID

IDEXX Laboratories Inc.

Health Care

1.70
PEGY ratio
Rank #406
Why This Matters

This stock appears overvalued relative to its growth and dividend yield. Strong projected growth of 25.5% annually over 5 years.

IDXX trades at 43.3x earnings against 25.5% growth (no dividend) (PEGY 1.70). The valuation appears stretched relative to the available growth and income.

~ Growth estimate uses historical CAGR (forward estimates unavailable)

  • • Growth rate derived from historical CAGR — limited analyst coverage.

Scan date: 2026-04-24

Valuation
43.3x
P/E Ratio
Growth
25.5%
5yr EPS
Income
0.0%
Div Yield
PEGY Components
PEGY Score1.70
Denominator25.5%
EPS (TTM)$13.07
Market Data
Price$565.93
ExchangeNASDAQ
S&P 500Nasdaq 100
What Changed
PEGY Score
1.77→1.70(-0.08)
Rank
#311→#406(95 positions)

vs 7 days ago

Portfolio Context

Founder does not hold this stock.

Not in your portfolio.

Sector: Health Care

PEGY History — 90 days
I Want to InvestNot Right Now
Data: Yahoo Finance • Updated nightly 11 PM ET • For informational purposes only